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ABSTRACTS0316 IS IT COST EFFECTIVE TO INTRODUCE INTRA-OPERATIVE
MOLECULAR ANALYSIS OF SENTINEL LYMPH NODES USING ONE STEP
NUCLEIC ACID AMPLIFICATION (OSNA)?
Amber Holmes, Ross Elledge, Michelle Mullan, Rachel Bright-Thomas,
Steven Thrush. Worcestershire Acute Hospitals Trust, Worcester, UK
Introduction: Axillary ultrasound is reported as having a sensitivity of 60-
72.7% in detecting metastatic lymph nodes, while intra-operative molec-
ular analysis with OSNA has a reported sensitivity of 91.7-100%. The
purpose of this audit was to assess the sensitivity of ultrasound within our
unit, thereby ascertaining cost effectiveness of introducing OSNA.
Methods: Patient records were audited retrospectively for all breast cancer
patients who underwent axillary lymph node dissection (ALND) between
December 2009 and November 2010 inclusive.
Results: A total of 184 sentinel lymph node biopsies (SLNB) and 75 ALNDs
were carried out during the audit period. Eighty-four per cent (n¼63) of
patients who underwent ALND had an ultrasound scan prior to surgery.
Ultrasound demonstrated a sensitivity of 41%, resulting in a return to
theatre for a completion axillary lymph node dissection (CALND) in 39
patients, incurring estimated additional costs of between £69,303 and
£100,386 and inpatient occupancy of between 62.01 and 140.4 inpatient-
days.
Conclusions: The sensitivity of axillary ultrasound was poorer than in the
literature. OSNA has been calculated to cost an additional £300 per
procedure, meaning additional costs of £55,200 for our department. This
would represent potential gains of up to £45,186, rendering the intro-
duction of OSNA highly cost effective.0321 THE IMPACT AND APPROPRIATENESS OF PATIENT PLACEMENT IN
ACUTE SURGICAL ADMISSIONS – A CLINICAL AUDIT
Eleanor King, Adam Peckham-Cooper. Leeds General Inﬁrmary, Leeds, West
Yorkshire, UK
Acute surgical admissions should be placed in an appropriate bed ﬁrst time
round for no longer than necessary. Little evidence for best practice exists
but variance could affect patient safety and experience, infection rates,
efﬁciency of seeing patients and increase elective cancellations. Demand
often outweighs bed availability and outlying is inevitable. Making this
safe, appropriate and minimising bed changes should be a priority. This
audit assesses patient placement with opinions of admitting consultants
and ward managers in a large inner-city teaching hospital.
Methods: A proforma was completed for all acute adult surgical admis-
sions in a 12 day period (n¼82). Opinions on appropriate wards for 12
common surgical conditions were collected from consultants (n¼12) and
ward managers (n¼14).
Results: 82 were admitted (median age 54; 35 male). 30% were allocated
appropriate wards and 20% non-surgical wards. 73% underwent at least
one ward transfer. 47 were placed inappropriately. Consultant and ward
manager opinions are presented.
Conclusions: Medical and nursing staff are unhappy outlying acute
surgical patients. Patients should be outlied in conjunctionwith guidelines
approved by admitting consultants and ward managers. A dedicated short
stay surgical assessment ward (48-72 hours) could improve patient safety,
increase efﬁciency and reduce length of patient stay.0325 CLINICAL OUTCOME AFTER CUBITAL TUNNEL DECOMPRESSION
S. Grant, M. Mohamed, F. Saedi, N. Hyder. Leighton Hospital, Leighton, UK
Introduction: The study was designed to evaluate the clinical outcome
after open in-situ decompression surgery for cubital tunnel syndrome.
Method: Ninety seven patients underwent in-situ decompression of the
cubital tunnel for ulnar nerve symptoms. Case records were reviewed
assessing severity of symptoms according to the McGowan scale.
Patients with a preceding injury, surgery or previous compression were
excluded.
Results: Eighty patients underwent primary decompression, seventeen
patients were excluded. According to the McGowan scale 10 patients had
grade I (12.5%), 57 (71.25 %) grade II and 7 grade III (8.75 %) symptoms.56 patients (70%) completed the outcome scale measure. 83.9% of patients'
overall symptoms were better or had been cured. 7 (12.5%) reported their
symptomsas thesameand2(3.57%)said theywereworsethanpre-operatively.
20 (35.7%) patients reported complete resolution of numbness, 24 (42.9%)
described mild and 12 (21.4%) described moderate numbness. 39 (69.6%)
had no night symptoms, with 13 (23.2%) and 4 (7.1%) describing occasional
or frequent night symptoms.
Conclusion: In-situ open primary cubital tunnel decompression is effec-
tive in improving symptoms related to ulnar nerve decompression.
Patients should be counselled the procedure is designed to stop progres-
sion of symptoms rather than provide complete resolution.0326 CLINICAL VALUE OF THE NUMBER OF POSITIVE DIAGNOSTIC
BIOPSY CORES IN PREDICTING BIOCHEMICAL RELAPSE IN MEN
TREATED FOR PROSTATE CANCER
Naveen Kachroo 1, Jack Dainty 2, Ajay Joseph 1, Anne Warren 3, Vincent
Gnanapragasam1. 1University of Cambridge, Cambridge, Cambridgeshire,
UK; 1 Institute of Food Research, Norwich, Norfolk, UK; 1Addenbrooke's
Hospital, Cambridge, Cambridgeshire, UK
Introduction: Tumour extent in diagnostic needle biopsies has been
proposed as a predictive marker of treatment response in prostate cancer.
Herewe tested its predictive value in men treated either for curative intent
by radical prostatectomy (RP) or palliative intent by primary androgen
deprivation therapy (PADT).
Patients and Methods: Clinical follow-up data was collected for men
treated by RP (n¼134) and by PADT (n¼127) in a tertiary centre. A second
PADT treated cohort from an independent tertiary centre was assessed for
validation (n¼134).
Results: 34% (46/134) and 54% (69/127) of men relapsed in the RP and
PADT groups respectively. In the RP cohort, the number of positive cores
emerged as independent factors associated with biochemical relapse
(p¼0.007). In the PADT cohort, the mean number of positive cores was
higher in relapsed men and those with metastasis (p<0.0001 and p¼0.03
respectively). The number of positive cores was signiﬁcantly associated
with biochemical relapse (p¼0.01), validated by the second cohort
(p¼0.006), on univariate but not multivariate analysis.
Conclusion: Scoring core positivity in diagnostic biopsies may have clin-
ical utility in predicting treatment response following surgery but has
doubtful value in PADT treated men and therefore does not currently
justify inclusion in universal predictive algorithms.0327 SIMULTANEOUS PROFILING OF MULTIPLE GENES IN ARCHIVAL
DIAGNOSTIC PROSTATE CANCER NEEDLE BIOPSIES
Naveen Kachroo 1, Ajay Joseph 1, Tania Murphy 1, Anne Warren 2, Vincent
Gnanapragasam1. 1University of Cambridge, Cambridge, Cambridgeshire, UK;
1Addenbrooke's Hospital, Cambridge, Cambridgeshire, UK
Introduction: Transcriptional proﬁling of archival formalin ﬁxed parafﬁn
embedded (FFPE) diagnostic needle biopsies with known clinical follow-
up, would represent a major step in investigating prognostic markers in
prostate cancer. Here we report an optimised approach for simultaneous
multi-gene expression analysis in archival biopsies.
Methods: Archival prostate biopsies linked to known clinical data were
identiﬁed. An optimised protocol was employed to extract RNA and syn-
thesise cDNA from epithelial tumour glands in 16 microdissected biopsies
of varying Gleason grade, with benign tissue samples used for comparison.
Results: cDNA was quality control tested against three housekeeping
genes prior to proﬁling expression of 29 promising biomarkers. All
tumours ampliﬁed successfully with known tumour marker PCA3 with no
expression in benign tissue, validating the approach (p¼0.0181, Mann-
Whitney Test). Variations were noted in the expression of particular genes
across different tumour grades including a downregulation of Sef, an
inhibitory regulator of ﬁbroblast growth factor signalling, in higher grade
tumours (p¼0.0039, Kruskal-Wallis Test).
Conclusions:We describe here an optimised method of proﬁling multiple
genes simultaneously in archival FFPE prostate needle biopsies. Current
work is aimed at utilising this method to deﬁne key gene panels to predict
outcome at diagnosis and help select the optimal treatment modality.
